Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, United States of America.
Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States of America.
Gynecol Oncol. 2018 Sep;150(3):494-500. doi: 10.1016/j.ygyno.2018.06.024. Epub 2018 Jun 30.
To evaluate predictors of receipt of follow-up instructions at completion of cancer treatment among women with breast and gynecologic cancers (cervical, endometrial, ovarian) in the United States, and determine if the factors differ by cancer type.
We designed a cross-sectional study using data from the "Cancer Survivorship" module of the 2016 Behavioral Risk Factor Surveillance System (BRFSS). We created logistic regression models to determine characteristics associated with receipt of follow-up care instructions, and stratified by models by cancer type to evaluate differences in factors.
Our sample included 954 (66%) and 492 (34%) women with breast and gynecologic cancers respectively. Even after adjustment, women treated for gynecologic cancer had 63% lower odds [0.37 (0.25-0.55)] of receiving follow-up instructions compared to women with breast cancer. Among breast cancer patients, those with an income <$25,000 per year had lower odds of receiving follow-up instructions [0.53(0.31-0.92)], while patients with high BMI (BMI ≥30 kg/m) had higher odds of receiving follow-up instructions [1.91 (1.15-3.18)]. Among gynecologic cancer patients, those diagnosed 51-75 years had higher odds of receiving follow-up instructions compared to those diagnosed ≤50 years [2.54 (1.13-5.70)].
In our study, gynecologic cancer patients less frequently received follow-up instructions compared to breast cancer patients. Receipt of follow-up instructions also differed by demographic and lifestyle factors. The results provide evidence for the need of public health initiatives to increase the frequency of follow-up instructions for gynecologic cancer patients, which can potentially increase the rate of follow-up and improve long-term outcomes.
评估美国女性乳腺癌和妇科癌症(宫颈癌、子宫内膜癌、卵巢癌)治疗结束时接受随访指导的预测因素,并确定这些因素是否因癌症类型而异。
我们使用 2016 年行为风险因素监测系统(BRFSS)“癌症生存”模块的数据设计了一项横断面研究。我们创建了逻辑回归模型,以确定与接受随访护理指导相关的特征,并按癌症类型分层模型,以评估因素差异。
我们的样本包括 954 名(66%)和 492 名(34%)分别患有乳腺癌和妇科癌症的女性。即使在调整后,接受妇科癌症治疗的女性获得随访指导的可能性也低 63%[0.37(0.25-0.55)],而患有乳腺癌的女性。在乳腺癌患者中,年收入<25,000 美元的患者获得随访指导的可能性较低[0.53(0.31-0.92)],而 BMI 较高(BMI≥30kg/m)的患者获得随访指导的可能性较高[1.91(1.15-3.18)]。在妇科癌症患者中,诊断为 51-75 岁的患者比诊断为≤50 岁的患者获得随访指导的可能性更高[2.54(1.13-5.70)]。
在我们的研究中,与乳腺癌患者相比,妇科癌症患者获得随访指导的频率较低。随访指导的获得也因人口统计学和生活方式因素而异。这些结果为需要开展公共卫生举措提供了证据,以增加妇科癌症患者获得随访指导的频率,这可能会提高随访率并改善长期结局。